106
Participants
Start Date
February 1, 2025
Primary Completion Date
February 1, 2028
Study Completion Date
June 1, 2028
transcutaneous auricular vagal nerve stimulation
"Participants will be randomly assigned to receive either taVNS applied to the tragus of the ear or a sham stimulation from the time of randomization for 90 days.~Active simulations will be carried out daily using the Parasym device for 60 minutes twice daily during the acute phase (two sessions, one in the morning and one in the afternoon), and once daily (single session) during the rehabilitation phase. The stimulation waveform includes trains of pulses with widths of 200 µs and repetition rate of 20 Hz (Nurosym proprietary waveform); current delivery will be set at a predefined therapeutic level below 0.25 W/cm² (Watts per centimeter squared), that being the defined risk threshold for a thermal burn. The device adjusts stimulation intensity at 0.8 mA steps; the starting intensity will be set at 16 mA (level 20)."
Sham (No Treatment)
The sham stimulation involves placing the electrode on the same site without delivering any electrical current. The device will be applied to the tragus without electrical current delivered from the time of randomization for 90 days (i.e., the time of randomization coincides with the first stimulation session).
Fondazione IRCCS San Gerardo dei Tintori, Monza
ASST Papa Giovanni XXIII, Bergamo
ASST degli Spedali Civili, Brescia
ASST Lariana Ospedale S. Anna, Como
Ospedale Policlinico San Martino IRCCS, Genova
ASST Grande Ospedale Metropolitano Niguarda, Milan
Humanitas Research Hospital, Rozzano
Azienda Ospedale Università di Padova, Padua
Azienda Ospedaliero Universitaria di Parma, Parma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
ASST Sette Laghi Ospedale di Circolo e Fondazione Macchi, Varese
University of Milano Bicocca
OTHER